— Know what they know.
Not Investment Advice

FEMY NASDAQ

Femasys Inc.
1W: -16.1% 1M: -32.9% 3M: -49.0% YTD: -83.7% 1Y: -72.3% 3Y: -90.6% 5Y: -98.6%
$2.05
-0.05 (-2.38%)
 
Weekly Expected Move ±9.6%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 34 · $6.2M mcap · 2M float · 21.65% daily turnover · Short 24% of daily vol

Cash Flow Trends

Operating Cash Flow
-$19M -72.4% ▼
Capital Expenditures
$762K -429.3% ▼
5Y CAGR: +1.8%
Free Cash Flow
-$20M -76.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$18M -308.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$7M-$8M-$11M-$14M-$19M
Depreciation & Amort.$1M$964K$889K$908K$872K
Stock-Based Comp.$319K$193K$225K$676K$444K
Change in Working Capital$558K-$733K-$458K$1M-$3M
Other Non-Cash Items$5K-$822K$6K$161K$1M
Operating Cash Flow-$5M-$8M-$11M-$11M-$19M
— Investing Activities —
Capital Expenditures-$8K-$307K-$407K-$144K-$762K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$1M$0$0$0$0
Other Investing-$23K$0$0$0-$86K
Investing Cash Flow$968K-$307K-$407K-$144K-$848K
— Financing Activities —
Net Debt Issuance$793K-$463K-$505K$6M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$75K-$2M-$236K$2M$2K
Financing Cash Flow$872K$30M-$682K$20M$2M
Net Change in Cash-$3M$21M-$12M$9M-$18M
Cash End of Period$3M$25M$13M$22M$3M
Free Cash Flow-$5M-$8M-$11M-$11M-$20M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms